BCRX files Form 144 to sell 11,180 shares

BCRX files a Form 144 notice to sell 11,180 shares of Common Stock.

Rhea-AI Filing Summary

BCRX files a Form 144 notice to sell 11,180 shares of Common Stock. The filing lists two stock-plan-related dispositions: 4,360 shares dated 06/07/2023 and 6,820 shares dated 06/12/2025. The broker shown is Merrill Lynch and the excerpt lists 254,162,660 shares outstanding as of 05/18/2026.

Insights

Securities Attorney

Form 144 lists a proposed resale of 11,180 shares by an affiliate under stock-plan activity.

Form 144 is a notice that an affiliate or control person intends to sell restricted or control stock; the excerpt identifies 11,180 shares total with specific plan-related lots of 4,360 and 6,820.

Timing and cash‑flow treatment are not provided in the excerpt; subsequent filing or trade reports would show execution details and purchaser treatment.

Key Figures

Registered/offered shares: 11,180 shares Plan lot 1: 4,360 shares Plan lot 2: 6,820 shares +2 more

5 metrics

Registered/offered shares 11,180 shares aggregate shown in securities section

Plan lot 1 4,360 shares Stock Plan Activity dated <date>06/07/2023</date>

Plan lot 2 6,820 shares Stock Plan Activity dated <date>06/12/2025</date>

Shares outstanding 254,162,660 shares as of <date>05/18/2026</date>

Trading venue NASDAQ exchange listed in securities information

Key Terms

Form 144, Stock Plan Activity, Issuer, Broker

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Plan Activity financial

"06/07/2023 | Stock Plan Activity | Issuer"

Issuer financial

"Stock Plan Activity | Issuer"

Broker financial

"Merrill Lynch 1800 K ST NW Suite 800"

A broker is a licensed professional or firm that helps investors buy and sell financial assets by executing trades on their behalf, acting like a marketplace agent or matchmaker between buyers and sellers. Brokers matter to investors because they provide access to markets, handle order execution and paperwork, and can offer research or advice—services that affect trade speed, costs, and the quality of investment decisions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCRX's Form 144 report?

It reports a proposed resale of 11,180 shares of common stock. The filing cites two plan-related lots: 4,360 (06/07/2023) and 6,820 (06/12/2025). The broker listed is Merrill Lynch.

Does the excerpt show who will receive proceeds from the sale for BCRX?

The excerpt does not state proceeds recipients. It lists the broker (Merrill Lynch) and share lots but does not attach cash‑flow treatment or indicate whether proceeds go to the issuer or selling holder.

How many BCRX shares are shown outstanding in the excerpt?

The excerpt shows 254,162,660 shares outstanding as of 05/18/2026. This figure appears in the securities information section and serves as a context figure in the filing excerpt.

Are the 11,180 shares part of a stock plan for BCRX?

Yes. The filing labels the reported lots as Stock Plan Activity, with entries dated 06/07/2023 (4,360 shares) and 06/12/2025 (6,820 shares), indicating plan‑related origins.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:48 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883764
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BIOCRYST PHARMACEUTICALS, INC.
SEC File Number	000-23186
Address of Issuer	4505 Emperor BLVD Suite 200 Durham NORTH CAROLINA 27703
Phone	9198591302
Name of Person for Whose Account the Securities are To Be Sold	Amy McKee
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1800 K ST NW Suite 800 Washington DC 20006	11180	99906	254162660	05/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2023	Stock Plan Activity	Issuer			4360	06/07/2023	n/a
Common	06/12/2025	Stock Plan Activity	Issuer			6820	06/12/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Amy McKee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)